Core protein: A pleiotropic keystone in the HBV lifecycle
- PMID: 26129969
- PMCID: PMC4537649
- DOI: 10.1016/j.antiviral.2015.06.020
Core protein: A pleiotropic keystone in the HBV lifecycle
Abstract
Hepatitis B Virus (HBV) is a small virus whose genome has only four open reading frames. We argue that the simplicity of the virion correlates with a complexity of functions for viral proteins. We focus on the HBV core protein (Cp), a small (183 residue) protein that self-assembles to form the viral capsid. However, its functions are a little more complicated than that. In an infected cell Cp modulates almost every step of the viral lifecycle. Cp is bound to nuclear viral DNA and affects its epigenetics. Cp correlates with RNA specificity. Cp assembles specifically on a reverse transcriptase-viral RNA complex or, apparently, nothing at all. Indeed Cp has been one of the model systems for investigation of virus self-assembly. Cp participates in regulation of reverse transcription. Cp signals completion of reverse transcription to support virus secretion. Cp carries both nuclear localization signals and HBV surface antigen (HBsAg) binding sites; both of these functions appear to be regulated by contents of the capsid. Cp can be targeted by antivirals - while self-assembly is the most accessible of Cp activities, we argue that it makes sense to engage the broader spectrum of Cp function. This article forms part of a symposium in Antiviral Research on "From the discovery of the Australia antigen to the development of new curative therapies for hepatitis B: an unfinished story."
Keywords: Antiviral therapy; Capsid; Hepatitis B Virus; Self-assembly.
Copyright © 2015 Elsevier B.V. All rights reserved.
Figures





Similar articles
-
Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.J Virol. 2018 Sep 26;92(20):e01082-18. doi: 10.1128/JVI.01082-18. Print 2018 Oct 15. J Virol. 2018. PMID: 30089690 Free PMC article.
-
Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.Antiviral Res. 2020 Oct;182:104917. doi: 10.1016/j.antiviral.2020.104917. Epub 2020 Aug 17. Antiviral Res. 2020. PMID: 32818519 Free PMC article. Review.
-
The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription.J Virol. 2015 Mar;89(6):3275-84. doi: 10.1128/JVI.03545-14. Epub 2015 Jan 7. J Virol. 2015. PMID: 25568211 Free PMC article.
-
Interaction between nucleophosmin and HBV core protein increases HBV capsid assembly.FEBS Lett. 2014 Mar 18;588(6):851-8. doi: 10.1016/j.febslet.2014.01.020. Epub 2014 Jan 23. FEBS Lett. 2014. PMID: 24462683
-
Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion.Biochem Pharmacol. 2003 Dec 15;66(12):2273-9. doi: 10.1016/j.bcp.2003.08.001. Biochem Pharmacol. 2003. PMID: 14637185 Review.
Cited by
-
A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01440-19. doi: 10.1128/AAC.01440-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31658963 Free PMC article.
-
Revisiting Hepatitis B Virus: Challenges of Curative Therapies.J Virol. 2019 Sep 30;93(20):e01032-19. doi: 10.1128/JVI.01032-19. Print 2019 Oct 15. J Virol. 2019. PMID: 31375584 Free PMC article. Review.
-
Characterization of Virus Capsids and Their Assembly Intermediates by Multicycle Resistive-Pulse Sensing with Four Pores in Series.Anal Chem. 2018 Jun 19;90(12):7267-7274. doi: 10.1021/acs.analchem.8b00452. Epub 2018 May 29. Anal Chem. 2018. PMID: 29708733 Free PMC article.
-
Molecular jenga: the percolation phase transition (collapse) in virus capsids.Phys Biol. 2018 Jun 6;15(5):056005. doi: 10.1088/1478-3975/aac194. Phys Biol. 2018. PMID: 29714713 Free PMC article.
-
Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms.Sci Rep. 2017 Feb 13;7:42374. doi: 10.1038/srep42374. Sci Rep. 2017. PMID: 28205569 Free PMC article.
References
-
- EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–185. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous